GLP-1 Medications for Weight Loss

GLP-1 receptor agonists have changed what's possible in medically supervised weight loss. Medications like semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) work with your body's own hormonal signals — reducing hunger, improving blood sugar control, and supporting sustainable fat loss in ways that diet and exercise alone often can't achieve.

At R Med+Spa in Durango, Dr. Brian Rike, DO supervises every GLP-1 weight loss program personally. That physician-led approach makes a meaningful difference in safety, dose management, and the results you can expect.

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) is a hormone your gut produces naturally after eating. It signals the pancreas to release insulin, tells the brain you've had enough food, and slows how quickly your stomach empties.

GLP-1 receptor agonists mimic this hormone — and address several of the biological drivers of weight gain at once:

Increased insulin secretion (glucose-dependent — low risk of hypoglycemia on its own)
Suppressed glucagon — the hormone that raises blood sugar between meals
Delayed gastric emptying — food stays in your stomach longer, so you feel full on less
Reduced appetite — direct action on hunger centers in the brain

These medications help you process glucose more efficiently *and* feel full sooner and for longer. Paired with proper diet and exercise, that combination produces results that are genuinely difficult to achieve otherwise.

How Much Weight Can You Lose?

Clinical evidence is compelling.

In the STEP 1 trial, participants using 2.4 mg semaglutide weekly achieved an average weight loss of 14.9% of their starting body weight over 68 weeks — compared to 2.4% in the placebo group. For a 200-pound person, that's roughly 30 pounds.

The SUSTAIN trial program demonstrated superior HbA1c reduction (1.8% versus 1.3% for comparable agents) alongside significant body weight reductions.

A landmark 2021 *New England Journal of Medicine* study confirmed that once-weekly semaglutide plus lifestyle intervention produced sustained, clinically meaningful weight reduction maintained for up to two years.

Individual results vary. Dr. Rike will help you set realistic expectations based on your starting point, health history, and specific goals.

Benefits Beyond the Scale

One of the most compelling aspects of GLP-1 medications is how broadly they improve health — not just weight.

Cardiovascular Protection

The SUSTAIN-6 cardiovascular outcomes trial showed semaglutide reduced the risk of major adverse cardiovascular events (MACE) — heart attack, stroke, and cardiovascular death — by 26% compared to placebo in high-risk patients. GLP-1 receptors are expressed in heart and vascular tissue, where their activation appears to confer direct protective effects. The SELECT trial further confirmed cardiovascular benefit in non-diabetic patients with obesity.

Kidney Health

Semaglutide has shown promise in slowing the progression of diabetic nephropathy and reducing albuminuria — a key marker of kidney damage — making it valuable for patients with metabolic risk factors beyond weight.

Liver Health

Non-alcoholic fatty liver disease (NAFLD) and its more serious form (NASH) are closely linked to obesity and insulin resistance. GLP-1 agonists have been shown to reduce liver fat content and improve liver histology — an important secondary benefit for many patients.

Anti-Inflammatory Effects

Chronic low-grade inflammation underlies much of the metabolic damage from excess weight. GLP-1 agonists reduce systemic inflammation markers, contributing to improved overall metabolic health.

Neuroprotective Effects

Emerging research suggests GLP-1 receptors in the brain may support cognitive function. Preliminary studies point to possible benefits in neurodegenerative conditions — a line of research that continues to evolve.

Bone Health

Preliminary evidence suggests semaglutide may improve bone density and reduce fracture risk by improving insulin sensitivity and reducing inflammation — particularly relevant for older adults and individuals with diabetes.

Common GLP-1 Medications

Several options are available depending on your health history and goals:

Semaglutide (Ozempic®, Wegovy®) — the most widely studied; once-weekly injection; FDA-approved for chronic weight management (Wegovy) and type 2 diabetes (Ozempic)
Liraglutide (Saxenda®, Victoza®) — daily injection; FDA-approved for chronic weight management and type 2 diabetes
Tirzepatide (Mounjaro®, Zepbound®) — a dual GIP/GLP-1 agonist; once-weekly; shown to produce even greater weight loss than semaglutide alone in head-to-head trials
Retatrutide — a triple-agonist (GLP-1, GIP, glucagon) in late-stage clinical development; [learn more about retatrutide →](/post/exploring-retatrutide-s-impact-on-metabolism-and-weight-loss-success)

Dr. Rike evaluates which medication is the best fit based on your medical history, current weight, and any concurrent conditions — including type 2 diabetes, high blood pressure, or cardiovascular risk.

What Treatment Looks Like

All GLP-1 medications are given as subcutaneous injections (just under the skin). Most patients self-inject at home after an initial demonstration at the practice.

Dose titration — starting low and increasing every 4 weeks minimizes early GI side effects
Frequency — once weekly for most agents; daily for liraglutide
Timeline — meaningful weight loss typically begins within 8–12 weeks; full benefit develops over 6–12 months of consistent use

Dr. Rike monitors your progress, labs, and any side effects throughout. Adjustments are made proactively — not reactively.

Side Effects and How to Manage Them

GLP-1 medications are generally well-tolerated, especially with gradual dose titration. Most side effects are gastrointestinal:

Nausea — the most common, especially early; tends to improve as your body adjusts
Vomiting — often triggered by increasing the dose too quickly
Diarrhea or constipation
Mild injection site redness or discomfort

For practical strategies on managing these side effects, see our dedicated guide: [Tips for Managing GLP-1 Side Effects →](/post/tips-for-offsetting-side-effects-from-glp-1-agonists-like-semaglutide)

Less common but important side effects:

Pancreatitis — seek medical care immediately for severe, persistent abdominal pain
Gallbladder disease — including gallstones and cholecystitis
Thyroid concerns — animal studies showed increased thyroid C-cell tumors at high doses; patients with a history of medullary thyroid carcinoma should not use these medications
Diabetic retinopathy — in patients with pre-existing retinal disease, close monitoring is recommended
Hypoglycemia risk increases when combined with insulin or sulfonylureas

Who Is a Good Candidate?

GLP-1 therapy may be appropriate if you have:

BMI ≥ 30, or BMI ≥ 27 with a weight-related condition (hypertension, type 2 diabetes, high cholesterol)
Difficulty achieving or maintaining weight loss through diet and exercise alone
Metabolic concerns such as pre-diabetes, elevated triglycerides, or fatty liver disease

Who Should NOT Use These Medications

GLP-1 agonists are not appropriate for everyone. You should avoid them if you have:

Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Type 1 diabetes mellitus
History of pancreatitis — discuss with Dr. Rike
Severe gastroparesis or serious gastrointestinal disease
Pregnancy — semaglutide should be discontinued at least 2 months before a planned pregnancy due to its long washout period; safety during breastfeeding has not been established
Active depression or suicidal ideation — discuss your full mental health history with Dr. Rike before starting

Older adults can use GLP-1 agonists safely, but closer monitoring for GI symptoms and hypoglycemia is appropriate. Patients with renal impairment may need dose adjustments.

Why Physician-Led Care Makes a Difference

GLP-1 medications are powerful tools — and that's precisely why medical oversight matters. At R Med+Spa, Dr. Rike:

Reviews your full health history and labs before prescribing
Titrates dosing based on your response, not a one-size-fits-all schedule
Monitors for side effects and adjusts proactively
Integrates weight management with your broader wellness goals

This isn't a prescription-and-go program. It's supervised care designed to get you lasting, safe results.

Ready to Get Started?

Call us at [(970) 501-0610](tel:+19705010610) or [book a Wellness Consult](/book) to find out if GLP-1 therapy is the right step for you.

*Individual results vary. GLP-1 medications require physician supervision and prescribing decisions are based on a thorough medical evaluation.*

GLP-1 Medications for Weight Loss: The Complete Guide